recall
saveAmerisource Health Services LLC recall (Cls II)
December 11, 2024updated 5mo ago
community read0 votes
Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx only, 1,000 count bottle, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-415-08 — Reason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit — Status: Ongoing
view source ↗Data sources
last refreshed 34m ago
Found something off?
same company · ±60 days · 6
- recallAmerisource Health Services LLC recall (Cls II)Dec 11, 2024
- recallAmerisource Health Services LLC recall (Cls II)Dec 11, 2024
- approvalERTUGLIFLOZIN: ERTUGLIFLOZIN — FDA approvalDec 9, 2024
- recallAmerisource Health Services LLC recall (Cls II)Jan 1, 2025
- recallAmerisource Health Services LLC recall (Cls II)Jan 1, 2025
- recallAmerisource Health Services LLC recall (Cls II)Jan 1, 2025
🐶 often sniffed alongside
top 8- tagApproval708 co-mentions · 354 sources
- tagSmall Molecule348 co-mentions · 348 sources
- companyAurobindo Pharma USA Inc81 co-mentions · 69 sources
- drugALDACTAZIDE60 co-mentions · 31 sources
- druglamotrigine SR38 co-mentions · 38 sources
- drugondansetron hydrochloride ODT29 co-mentions · 29 sources
- drugondansetron ODT29 co-mentions · 29 sources
- drugONDANSETRON29 co-mentions · 29 sources
comments(0)
5-min edit window · permanent after that